Sandra Robelet
YOU?
Author Swipe
View article: <p>Effect of the micro-immunotherapy medicine 2LPARK® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson’s disease</p>
Effect of the micro-immunotherapy medicine 2LPARK® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson’s disease Open
Our results demonstrate the in vitro efficacy of MIM on two essential mechanisms of PD and propose the MI approach as a new ally in the regulation of neuroinflammation and in the treatment of this degenerative disease.
View article: Effect of 2LMISEN&lt;sup&gt;&#174;&lt;/sup&gt; on Long-Term Hippocampal Neurons Culture as a Screening Senescent Cells Model: p16&lt;sup&gt;INK4A&lt;/sup&gt; and Caspase 3 Quantification
Effect of 2LMISEN<sup>®</sup> on Long-Term Hippocampal Neurons Culture as a Screening Senescent Cells Model: p16<sup>INK4A</sup> and Caspase 3 Quantification Open
The aim of the present study was to investigate the effect of one capsule of the micro-immunotherapy medicine (MIM) 2LMISEN® compared to vehicle, in a neuronal aging model. Senescence and apoptosis of hippocampal neurons were evaluated by …
View article: Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson’s disease
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson’s disease Open
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterised by the loss of dopaminergic nigrostriatal neurons but which involves the loss of additional neurotransmitter pathways. Mono- or polytherapeutic intervention…